BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9350483)

  • 41. Cortisol and estradiol: nongenetic factors for hyperhomocyst(e)inemia.
    Kim MH; Kim E; Passen EL; Meyer J; Kang SS
    Metabolism; 1997 Mar; 46(3):247-9. PubMed ID: 9054464
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia.
    Ubbink JB
    J Inherit Metab Dis; 1997 Jun; 20(2):316-25. PubMed ID: 9211204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Homocysteine as a novel risk factor for atherosclerosis.
    Guthikonda S; Haynes WG
    Curr Opin Cardiol; 1999 Jul; 14(4):283-91. PubMed ID: 10448607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of folic acid, pyridoxal phosphate and cobalamin on plasma homocyst(e)ine levels and the susceptibility of low-density lipoprotein to ex-vivo oxidation.
    Weiss N; Feussner A; Hailer S; Spengel FA; Keller C; Wolfram G
    Eur J Med Res; 1999 Oct; 4(10):425-32. PubMed ID: 10527956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperhomocyst(e)inemia.
    Key NS
    Curr Treat Options Cardiovasc Med; 2000 Feb; 2(1):65-72. PubMed ID: 11096511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The many flavors of hyperhomocyst(e)inemia: insights from transgenic and inhibitor-based mouse models of disrupted one-carbon metabolism.
    Elmore CL; Matthews RG
    Antioxid Redox Signal; 2007 Nov; 9(11):1911-21. PubMed ID: 17696766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyperhomocyst(e)inemia, related vitamins and dementias.
    Delport R
    J Nutr Health Aging; 2000; 4(4):195-6. PubMed ID: 11115799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
    Coull BM; Malinow MR; Beamer N; Sexton G; Nordt F; de Garmo P
    Stroke; 1990 Apr; 21(4):572-6. PubMed ID: 2326839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperhomocyst(e)inemia: a risk factor for cerebrovascular disease.
    Parnetti L; Caso V; Amici S; Lanari A; Gallai V; Bottiglieri T
    Clin Exp Hypertens; 2002; 24(7-8):501-9. PubMed ID: 12450225
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperhomocyst(e)inemia induces accelerated transplant vascular sclerosis in syngeneic and allogeneic rat cardiac transplants.
    Cook JW; Yin Q; Malinow MR; Orloff SL
    Am J Transplant; 2002 Mar; 2(3):244-51. PubMed ID: 12096787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia.
    Watanabe M; Osada J; Aratani Y; Kluckman K; Reddick R; Malinow MR; Maeda N
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1585-9. PubMed ID: 7878023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperhomocyst(e)inemia is a risk factor of secondary vascular events in stroke patients.
    Del Ser T; Barba R; Herranz AS; Seijas V; López-Manglano C; Domingo J; Pondal M
    Cerebrovasc Dis; 2001 Aug; 12(2):91-8. PubMed ID: 11490102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation).
    Shenoy KT; Lena KB; Sali N; Syam S; Shenoy ST; Rajadhyaksha VD; Pai GP; Shaikh AA;
    Curr Med Res Opin; 2006 Apr; 22(4):641-8. PubMed ID: 16684424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Are fasting plasma homocyst(e)ine levels heritable? A study of normotensive twins.
    Cesari M; Burlina AB; Narkiewicz K; Sartori MT; Sacchetto A; Rossi GP
    J Investig Med; 2000 Sep; 48(5):351-8. PubMed ID: 10979240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Defects in homocysteine metabolism: diversity among hyperhomocyst(e)inemias.
    Matthews RG; Elmore CL
    Clin Chem Lab Med; 2007; 45(12):1700-3. PubMed ID: 17937607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Homocysteine and cardiovascular disease].
    Skovby F; Dyerberg J; Nexø E; Osler M; Rasmussen K; Stender S
    Ugeskr Laeger; 2001 Mar; 163(13):1830-3. PubMed ID: 11293310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nutritional supplementation in the management of hyperhomocyst(e)inemia: an update.
    Shaikh A
    Indian Heart J; 2000; 52(7 Suppl):S31-34. PubMed ID: 11339438
    [No Abstract]   [Full Text] [Related]  

  • 58. Homocyst(e)ine and stroke.
    Furie KL; Kelly PJ
    Semin Neurol; 2006 Feb; 26(1):24-32. PubMed ID: 16479441
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Measurement of methylmalonic acid, homocysteine and methionine in cobalamin and folate deficiencies and homocysteinuria].
    Ueland PM; Schneede J
    Tidsskr Nor Laegeforen; 2008 Mar; 128(6):690-3. PubMed ID: 18337849
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperhomocyst(e)inaemia in children with chronic renal failure.
    Lilien M; Duran M; Van Hoeck K; Poll-The BT; Schröder C
    Nephrol Dial Transplant; 1999 Feb; 14(2):366-8. PubMed ID: 10069190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.